IVERIC bio Inc. Stock
Your prediction
IVERIC bio Inc. Stock
Our community identified positive and negative aspects for IVERIC bio Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the IVERIC bio Inc. stock. On the other hand our users think that "Management" could be a problem in the future.
Pros and Cons of IVERIC bio Inc. in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
B****
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of IVERIC bio Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| IVERIC bio Inc. | - | - | - | - | - | - | - |
| Larimar Therapeutics Inc. | -1.080% | -17.544% | 51.613% | 64.912% | 13.253% | -28.381% | -73.484% |
| Vaxart Inc. | -2.590% | 2.655% | 28.889% | 3.757% | 107.143% | -19.400% | -89.358% |
| Celldex Therapeutics | -2.290% | -3.759% | 30.612% | 36.898% | 16.364% | -35.157% | 23.077% |
Comments
IVERIC bio, Inc. (NASDAQ: ISEE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for ISEE provided by MarketBeat
IVERIC bio, Inc. (NASDAQ: ISEE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for ISEE provided by MarketBeat
IVERIC bio, Inc. (NASDAQ: ISEE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for ISEE provided by MarketBeat